Moberg Pharma is developing MOB-015, which is believed to be the most successful therapy amongst all the other expected drug candidates and shall account for the highest Onychomycosis market revenue in the coming years
NEWARK, Del, July 06, 2022 (GLOBE NEWSWIRE) — As per the recent edition of the Onychomycosis Treatment Market report, ESOMAR-certified market research and consulting firm Future Market Insights offers projections about key factors driving the demand. Technological advancements and increasing awareness of this condition are likely to propel the growth of the Onychomycosis treatment market across the globe.
Onychomycosis is a very common condition that causes a fungal infection of the fingernails or toenails. Onychomycosis is subjected to significant negative effects on a patient’s emotional, social, and occupational functioning. It may lead to social exclusion and stigmatization. The emergence of improved systemic treatment regimens in the last two decades is helping increase the number of people receiving treatment for this disease.
Get Sample PDF of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1279
According to Future Market Insight’s detailed analysis, an increase in the diagnosis of nail infections has helped widespread awareness of this condition with an estimated market growth at a CAGR of 5% between 2016 and 2020. It has in turn fueled the demand for effective medications. Driven by the above factors and increasing patient pool, the demand for onychomycosis treatment is expected to progress with a remarkable CAGR of 7% through the forecast period (2021-2031).
- An increase in awareness about the condition has fueled the demand for effective medications. The rising prevalence of onychomycosis has elevated the demand for nail lacquers treatment, driving the growth of onychomycosis treatment market.
- Development of new drugs in the pipeline such as Novexatin topical nail fungus treatment for onychomycosis has been enabling growth in the market.
- KX2-391 is another promising recent phase III addition that is being developed by Almirall, S.A for the treatment of onychomycosis.
- Rapid development in the drug delivery process for treatment of onychomycosis diseases has encountered an ever-growing number of patients which is resulting in the notable shift towards combination treatment has spurred the market growth through the forecast years.
- North America is projected to emerge as the most lucrative market for onychomycosis treatment, forecasting to exhibit a CAGR of over 7% during the forecast period.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1279
Teva Pharmaceutical Industries Ltd., Sanofi S.A., Medimetriks Pharmaceuticals, Inc., Galderma, Johnson & Johnson, Novartis AG, Moberg Pharma AB, Cardinal Health, Inc., Pfizer Inc., Almirall, S.A., Bayer AG, Viatris Inc., GlaxoSmithKline plc, Cipla Ltd., Dr. Reddy’s Laboratories Ltd are some of the key companies profiled in the full version of the report.
To gain a competitive edge in the market, key companies and manufacturers in the onychomycosis treatment market are aiming to carry out strategic collaborations such as acquisitions and mergers to increase awareness across the globe.
More Insights into the Onychomycosis Treatment Market
In its latest report, FMI offers an unbiased analysis of Onychomycosis treatment covering sales outlook, demand forecast & up-to-date key trends. The market is segmented on the basis of type (Drugs: Oral, Rx, OTC,), (Laser: C02 Ablative Lasers, Nd:YAG Lasers, Dual-wavelength near-infrared Lasers), (Photodynamic Therapy), Disease Indication ( Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candidal Onychomycosis, Total Dystrophic Onychomycosis), age group, (0-18 years, 18-39 years, 40-64 years, 65 years & above), gender (male, female), distribution channel (Institutional Sales: Hospitals, Dermatology Clinics, Retail Sales: Retail Pharmacies, Drug Stores, Mail Order Pharmacies & Online Sales) region (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA)).
According to FMI projections North America is anticipated to emerge as the dominant region accounting for the highest onychomycosis treatments, exhibiting a CAGR of over 7% during the forecast period. The increase in the prevalence of risk factors such as diabetes which has higher chance to cause onychomycosis is one of the key factors that is making the U.S. one of the most lucrative markets for onychomycosis treatment.
Germany is among the top countries that spend a significant amount on healthcare. People’s shifting abilities to spend more on healthcare has increased awareness about onychomycosis conditions. Constant improvements in healthcare infrastructure are enabling the growth of effective onychomycosis treatment in the German market.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1279
Onychomycosis Treatment Market by Category
- C02 Ablative Lasers
- Nd:YAG Lasers
- Dual-wavelength near-infrared Lasers
- Photodynamic Therapy
- Distal Subungual Onychomycosis
- White Superficial Onychomycosis
- Proximal Subungual Onychomycosis
- Candidal Onychomycosis
- Total Dystrophic Onychomycosis
- 0-18 Years
- 18-39 Years
- 40-64 Years
- 65 Years & Above
- Institutional Sales
- Dermatology Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies & Online Sales
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa (MEA)
Buy Now@ https://www.futuremarketinsights.com/ask-question/rep-gb-1279
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Treatment Regime (Prescription Pattern)
4.3. Key Regulation Scenario
4.4. Pipeline Analysis
4.5. Reimbursement Scenario
About the Healthcare Division at Future Market Insights
The Healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analysing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Have a Look at Related Research Reports:
Oncology Information Systems Market Size: The oncology information systems market was worth $3,082.3 million in 2022 and is expected to grow to $5,538.66 million by 2032, at a CAGR of 6% from 2022 to 2032.
Immunostimulants Market Share: Global demand for immunostimulants is set to increase at a 6.2% CAGR from 2022 to 2032, reaching around US$ 108.2 Bn in 2022. According to a recent study by Future Market Insights (FMI), vaccines held a substantial share of more than 62% in 2021 within the global immunostimulants market.
Herpes Simplex Keratitis Treatment Market Trends: The global herpes simplex keratitis treatment market size is anticipated to reach US$ 4.2 Billion in 2022. It is expected to be valued at US$ 7.9 Billion in 2032 and exhibit growth at a robust CAGR of 6.1% in the forecast period from 2022 to 2032.
Multi-channel Remote ECG Monitors Market Forecast: The global multi-channel remote ECG monitors market is forecasted to be appraised at US$ 314.7 Mn by 2032, up from US$ 187.8 Mn in 2022, advancing at a CAGR of 4.8% during the forecast period.
MRI-Safe Neurostimulation Systems Market Analysis: The global MRI-safe neurostimulation systems market size is expected to reach US$ 1,210.0 Million by 2032.
Leukemia Therapeutics Treatment Market Size – During the forecast period, the leukemia therapeutics treatment market is expected to record a CAGR of 7.1 per cent to reach a valuation of US$ 17 Bn by 2024, from a valuation of US$ 13 Bn in 2020
Phototherapy Treatment Market Outlook – Phototherapy Treatment Market By Disease Type (Psoriasis, Acne), Phototherapy (Blue Light Phototherapy, Red Light Phototherapy, Intense Pulsed Light (IPL) Phototherapy), End User (Hospitals, Dermatology Clinics/Skin Care Centres, Wellness Centres) & Region – Forecast 2021 – 2027
Hirschsprung Disease Treatment Market Demand – Market Insights on Hirschsprung Disease Treatment covering sales outlook, demand forecast & up-to-date key trends
Pulmonary Arterial Hypertension Treatment Market – Pulmonary Arterial Hypertension Treatment Market By Drug (Vasodilators, Phosphodiesterase 5 (PDE 5) Inhibitors, Endothelin Receptor Antagonists (ERA), Soluble Guanylate Cyclase (SGC) Stimulator), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) & Region – Forecast 2022 – 2028
Small Cell Lung Cancer (SCLC) Treatment Market Share – Market Insights on Small Cell Lung Cancer (SCLC) Treatment covering sales outlook, demand forecast & up-to-date key trends
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: firstname.lastname@example.org
Browse Other Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs